Thursday, December 1, 2022
- CMS Urges Timely Patient Access to COVID-19 Vaccines, Therapeutics
- Quality Payment Program: Preview Your Performance Information by December 20
- Clinical Laboratory Fee Schedule: CY 2023 Final Payment Determinations
- HIV: Screening is Knowledge
- National Fee Schedule for Medicare Part B Vaccine Administration
- New Waived Tests
- New & Expanded Flexibilities for Rural Health Clinics & Federally Qualified Health Centers during the COVID-19 PHE — Revised
- Home Health Claims: New Grouper Edits — Revised
On November 22, CMS issued new guidance that highlights the need for health care providers and suppliers to ensure patients have access to the latest available COVID-19 vaccines and therapeutics. In particular, CMS is reminding nursing homes that they are required to offer the COVID-19 vaccines, including any updated COVID vaccines, to residents.
See the full news alert.
Learn more about the 2021 Preview Period and public reporting at Care Compare: Doctors and Clinicians Initiative.
View the CY 2023 Clinical Laboratory Fee Schedule final payment determinations. Ask CMS to reconsider payment amounts or basis of payment by January 28. We’ll review reconsiderations at the 2023 Annual Public Laboratory meeting.
According to the CDC, nearly 1.2 million people in the U.S. had HIV in 2019, and about 13% didn’t know they had it (see CDC). Screening is the only way to know for sure if a patient has HIV. Knowing HIV status gives patients powerful information to help them take steps toward better health. World AIDS Day is the perfect time to talk with your patients about HIV prevention and screening.
Medicare covers HIV screening, and your patients pay nothing if you accept assignment. Find out when your patient is eligible for this screening. If you need help, contact your eligibility service provider.
- HIV/AIDS Disparities data snapshot, December 2020
- CDC HIV webpage
- Administration for Community Living HIV/AIDS webpage
- HIV screenings: Get information for your Medicare patients
Shared decision-making (SDM) is an important part of person-centered health care. You work with your patient to make decisions that meet their needs based on:
- Evidence-based information about available options
- Your knowledge and experience
- Patient's values and preferences
When you provide SDM for percutaneous left atrial appendage closure (LAAC) and implantable cardioverter defibrillators (ICDs):
- Document the SDM encounters correctly in medical records before you implant.
- Get preoperative documents from all providers before submitting medical records. While not mandatory, it speeds processing of your claims.
The Comprehensive Error Rate Testing (CERT) contractor reviews your claim documentation to determine if it meets SDM requirements. If it doesn’t, CMS will:
- Issue an error for overpaid claims for these procedure codes
- Recoup the overpayment
Learn about payment for CY 2023:
- Updated amount and codes for vaccine administration
- COVID-19 vaccine administration codes
- New tests approved by the FDA
- Using modifier QW
New & Expanded Flexibilities for Rural Health Clinics & Federally Qualified Health Centers during the COVID-19 PHE — Revised
Learn about the 2023 payment rate for distant site telehealth services.
CMS won’t return claims with this message, “Primary diagnosis identified as a code first code with condition present.”
Learn about what's changed:
- New Medicare Part B immunosuppressive drug benefit
- Preventive services eligibility data
Use this infographic from the FDA to talk with your patients about biologics and biosimilars.
Patients with Medicare because of ESRD currently lose coverage 36 months after a kidney transplant unless otherwise eligible for Medicare. When their coverage is about to end, CMS will mail them a letter to explain other coverage options, including:
- Employer coverage
- Health Insurance Marketplace®
- Medicaid and the Children’s Health Insurance Program
- Continuing Medicare coverage
If your patient doesn’t have or expect to get other health insurance, they may qualify for the new Part B immunosuppressive drug benefit. It only covers immunosuppressive drugs and no other items or services.
When your patient gets this letter, they need to:
- Think about how they want to get their health coverage
- Act to make sure they have health coverage when their Medicare coverage ends
Get information on ESRD for your patients.
This newsletter is current as of the issue date. View the complete disclaimer.
The Medicare Learning Network®, MLN Connects®, and MLN Matters® are registered trademarks of the U.S. Department of Health and Human Services (HHS).